ABSTRACT
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome, characterized by accumulation of fat on the liver parenchyma with a heterogeneous clinical presentation. In recent years its prevalence and incidence has been increasing in association with the rise in obesity and its comorbidities, becoming one of the main causes of cirrhosis. The cause of NAFLD is multifactorial, and currently the role of intestinal microbiota and its interaction with the metabolic syndrome and NAFLD has become of interest. Different pathophysiological phenomena have emerged, the main being intestinal dysbiosis, loss of intestinal barrier, bacterial translocation, with activation of inflammation and oxidative stress, and production of active metabolites, such as ethanol. The management of this factor seems promising and adds to the classic approach of changes in lifestyle. Probiotics are the most studied tool and show evidence of effectiveness, however further studies are needed.
La enfermedad por hígado graso no alcohólico (EHGNA) es la manifestación hepática del síndrome metabólico,caracterizándose por acumulación de grasa a nivel del parénquima con una heterogénea presentación clínica. En los últimos años su prevalencia e incidencia ha ido en aumento, en asociación al aumento de la obesidad y sus comorbilidades, transformándose en una de las principales etiologías de cirrosis hepática. La causa de la EHGNA es multifactorial, siendo de interés en la actualidad el rol de la microbiota intestinal y su interacción con el síndrome metabólico y la EHGNA. Distintos fenómenos fisiopatológicos se han planteado, siendo los principales la disbiosis intestinal, la pérdida de la barrera intestinal, la translocación bacteriana con activación de la cascada de la inflamación y estrés oxidativo y la producción de metabolitos activos como el etanol. El manejo de este factor parece promisorio y se agrega al clásico enfrentamiento de cambios en estilo de vida. Los probióticos son la herramienta más estudiada y disponen de evidencia de efectividad, pero con necesidad de mayores estudios.
Subject(s)
Humans , Non-alcoholic Fatty Liver Disease/microbiology , Non-alcoholic Fatty Liver Disease/therapy , Exercise , Fatty Liver/physiopathology , Gastrointestinal Microbiome , Probiotics/therapeutic useABSTRACT
Celiac disease (CD) is an autoimmune pathology caused by the ingestion of gluten in genetically susceptible people, currently considered multisystemic. The treatment of CD is a lifelong strict Gluten-Free Diet (GFD), which allows a symptomatic improvement in most patients and achieve intestinal mucosa healing confirmed with histological study. The adherence to the GFD is variable, arguing as possible factors related to failure the economic, cultural, social aspects and the consumption of gluten inadvertently. The management of celiac patients contemplates instructing in the proper follow-up of GFD and evaluating their adherence. So far, the only way to assess adherence to GFD is through surveys, self-reports of eating habits and serology, being the main disadvantage the subjectivity factor. Recently the immunogenic gluten peptides have acquired relevance for the objective evaluation of the adherence to the GFD and the measurement appears as an efficient and sensitive option to determine the gluten intake, providing relevant information for the clinical management.
Subject(s)
Male , Female , Humans , Celiac Disease/immunology , Glutens/analysis , Glutens/metabolism , Peptides/analysis , Peptides/immunologyABSTRACT
Upper gastrointestinal bleeding secondary to acute variceal hemorrhage is a medical emergency, with significant morbidity and mortality, which usually requires a multidisciplinary approach from gastroenterologists, intensive care physicians, and surgeons. The most common cause of variceal bleeding is the one that arises from portal hypertension associated with cirrhosis, and best described in terms of prevention, initial management and following treatment that in the minority of cases can be definitive without complex interventions, including liver transplant in cirrhotic patients. Within the etiologies not arising from portal hypertension, splenic vein thrombosis is one of the most important. Characterized by an endoscopic appearance of fundal or isolated gastric varices, without esophageal involvement, a variable number of cases manifest clinically as variceal hemorrhage. Based on different pathophysiology compared to esophageal varices, response to initial treatment is different, endoscopic management involve the use of adhesives (e.g. cyanoacrylate) as treatment of choice, and, in selected cases, surgical treatment can provide a definitive solution. Here we present a clinical case of an adult patient, without history of cirrhosis, who presented to the emergency department with severe upper gastrointestinal bleeding secondary to gastric varices, admitted in Intensive Care Unit and treated with endoscopy. Complementary studies with abdominal CT showed spleen vein thrombosis, enlarged spleen and multiple varicesin gastric body and fundus. After stabilization, splenectomy was performed as definitive treatment, with regression of gastric varices on ambulatory control with an upper endoscopy...
La hemorragia digestiva alta por sangrado variceal agudo constituye una emergencia médica, con morbimortalidad significativa asociada, requiriendo manejo multidisciplinario de gastroenterólogos, intensivistas y cirujanos. El sangrado variceal por hipertensión portal secundario a daño hepático crónico es el más habitual y mejor caracterizado en prevención, enfrentamiento inicial y manejo posterior, que en la minoría de los casos puede ser definitivo, sin intervenciones complejas, incluyendo trasplante hepático en pacientes cirróticos. Dentro de las causas de sangrado variceal no asociadas a hipertensión portal, la trombosis de vena esplénica es una de las principales. Caracterizada por presentarse en endoscopia como várices gástricas fúndicas o aisladas sin compromiso esofágico, se manifiestan clínicamente como sangrado variceal agudo en un porcentaje variable de casos. Por tener etiopatogenia distinta a las várices por hipertensión portal, la respuesta frente a las medidas terapéuticas iniciales es distinta, el tratamiento endoscópico de elección es el uso de adhesivos tipo cianoacrilato, y en casos seleccionados, el enfrentamiento quirúrgico puede ofrecer una solución definitiva. Presentamos el caso de una paciente sin antecedentes de daño hepático crónico, que se presentó con hemorragia digestiva alta por sangrado de várices gástricas, con manejo inicial en unidad de paciente crítico y hemostasia por vía endoscópica. En estudio complementario se objetivó trombosis de la vena esplénica con esplenomegalia y múltiples formaciones varicosas en fondo y cuerpo gástrico. Posterior a estabilización se realizó esplenectomía como manejo definitivo, logrando regresión de várices gástricas en endoscopia de control...